Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans [NA]

View source ↗

Summary

A clinical trial update reports the completion of a bioequivalence study evaluating Trifluridine and Tipiracil hydrochloride tablets under fasting and fed condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trifluridine and tipiracil hydrochloride tablets (trifluridine/tipiracil)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Solid Tumor Cancer | NA | Status: COMPLETED